Karolin Trautmann-Grill

10PUBLICATIONS
77CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Mar 20, 2026
Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Maximilian Alexander Röhnert, Anna Seifert, Karolin Trautmann-Grill

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Jan 07, 2026
Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia.

Annaïse J Jauch, Paul Schmidt-Barbo, Christoph Schultheiss

|Jan 17, 2025
Communicating cancer treatment with pictogram-based timeline visualizations.

Helena Klara Jambor, Julian Ketges, Anna Lea Otto

|Dec 09, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Elias K Mai, Uta Bertsch, Ema Pozek

Pageof 2

Frequent Collaborators

4 joint publications

Hartmut Goldschmidt

3 joint publications

Hans J Salwender

3 joint publications

Christian S Michel

3 joint publications

Tobias A W Holderried